← Back to Search

Telehealth Support for Type 1 Diabetes

N/A
Recruiting
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of type 1 diabetes with a duration of >12 months
Age 5-18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months prior to study; 6 months during study
Awards & highlights

Study Summary

This trial will test if extra video visits and remote monitoring can help kids with uncontrolled type 1 diabetes better manage their blood sugar levels over 6 months, and compare how well these two interventions work compared to usual care.

Who is the study for?
This trial is for kids aged 5-18 with type 1 diabetes who've had it for over a year. They need to have high blood sugar levels and be able to get online care at the UCD Pediatric Diabetes Clinic in California. They can't join if they don't live in California.Check my eligibility
What is being tested?
The study looks at whether extra video visits or remote monitoring help control blood sugar better than usual care alone, over six months, for young patients with poorly controlled type 1 diabetes.See study design
What are the potential side effects?
Since this trial involves standard care and additional telehealth services rather than medication, there are no direct side effects from treatments like you'd expect with drugs.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have had type 1 diabetes for more than 12 months.
Select...
You must be between 5 and 18 years old.
Select...
You plan to get diabetes care at the UCD Pediatric Diabetes Clinic in the next year.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months prior to study; 6 months during study
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months prior to study; 6 months during study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glycemic control
Secondary outcome measures
Healthcare utilization
Patient-reported outcomes

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Supplemental video visitsExperimental Treatment2 Interventions
Participants in this intervention arm will receive home-based video visits with a pediatric endocrinologist every month for the duration of 6 months in addition to usual care.
Group II: Supplemental remote monitoringExperimental Treatment2 Interventions
Participants in this intervention arm will receive remote glucose monitoring with monthly asynchronous outreach from a pediatric endocrinologist for a duration of six months in addition to usual care.
Group III: Standard of CareActive Control1 Intervention
The control group will receive usual care, consisting of quarterly visits with the UCD Pediatric Diabetes Clinic.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Standard of Care
2017
Completed Phase 4
~4420

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
908 Previous Clinical Trials
4,704,015 Total Patients Enrolled

Media Library

Standard of Care Clinical Trial Eligibility Overview. Trial Name: NCT04428658 — N/A
Type 1 Diabetes Research Study Groups: Supplemental video visits, Standard of Care, Supplemental remote monitoring
Type 1 Diabetes Clinical Trial 2023: Standard of Care Highlights & Side Effects. Trial Name: NCT04428658 — N/A
Standard of Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04428658 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any restrictions to enrolling in this medical survey?

"This clinical trial is searching for one hundred children aged between five and eighteen years old, who are living with diabetes or autoimmune disorders. Furthermore, they must have inadequate glycemic control (HbA1c > 8%/64 mmol/mol), a minimum of twelve months since the date of type 1 diabetes diagnosis, access to an internet-enabled device that supports audio and video technology, as well as Bluetooth or physical cable capabilities for connecting their home glucose monitor and insulin pump - if applicable."

Answered by AI

How many individuals is this clinical trial enrolling?

"Affirmative. The clinicaltrial.gov database reveals that this trial is presently enrolling candidates, having been posted on September 15th 2022 and last updated a fortnight later. An approximate hundred subjects are being sought at one specified site."

Answered by AI

Is participation in this scientific research limited to those aged 75 or below?

"This study has outlined an age range for inclusion of 5 to 18 years old. As such, there are 216 trials that cater exclusively to minors and 920 studies suitable for patients over the retirement age."

Answered by AI

Is there still availability for participants in this medical demonstration?

"The data posted on clinicaltrials.gov affirms that this medical study, which was originally advertised on September 15th 2022, is actively seeking participants. The trial details were last updated on the 29th of the same month."

Answered by AI
~40 spots leftby Mar 2025